Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore - Centre for Endoscopic Research Therapeutics and Training (CERTT), Rome, Italy (Luis Marín Calderón, Rossella Maresca, Frederico Barbaro, Cristiano Spada).
Federico Barbaro studies a variety of gastrointestinal conditions, especially those concerning cancer risks in patients undergoing screening and treatment. His research explores how artificial intelligence can enhance the early detection of precancerous lesions in the colon, and how the gut microbiome may serve as a non-invasive screening tool for colorectal cancer. Additionally, he investigates the management of specific lesions at the esophagogastric junction and the impacts of different treatments for patients with chronic conditions such as Hepatitis D and C, including their risks for developing liver cancer.
Key findings
Computer-assisted detection of adenomas improved detection rates from 59.8% to 67.6% during colonoscopy screenings.
In a study of hyperplastic EGJ lesions, 23% were found to have changed to cancer, emphasizing the need for careful monitoring.
Gut microbiome patterns showed potential as a non-invasive colorectal cancer screening tool, differentiating patients with cancer from healthy individuals.
Endoscopic submucosal dissection (ESD) achieved complete tumor removal in 95.8% of inflammatory bowel disease patients at risk for colorectal cancer.
Patients treated for hepatitis C with direct-acting antivirals had a 64% lower risk of developing liver cancer compared to untreated individuals.
Frequently asked questions
Does Dr. Barbaro study colorectal cancer?
Yes, Dr. Barbaro's research significantly focuses on colorectal cancer, particularly in improving detection and treatment methods.
What treatments has Dr. Barbaro researched?
He has researched treatments for precancerous lesions and cancers related to the gastrointestinal tract, including therapies for Hepatitis C.
Is Dr. Barbaro's work relevant to patients with liver disease?
Yes, his work on hepatitis treatments and their effects on liver cancer risks is directly relevant to patients with liver disease.
What new screening methods is Dr. Barbaro exploring?
He is exploring the use of gut microbiome patterns as a potential non-invasive screening tool for colorectal cancer.
Can Dr. Barbaro's findings help older patients?
Yes, his studies highlight important considerations for older patients undergoing gastrointestinal procedures, particularly the increased risks they may face.
Publications in plain English
Letter to the editor: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP.
2026
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Brunoro R, Mengato D, Barbaro F, Calandrino L, Cattelan AM +1 more
Endoscopic Management of Malignancy-Related Gastrointestinal Bleeding: A Comprehensive Narrative Review.
2026
Medical sciences (Basel, Switzerland)
Salvi D, Parmigiani M, Spada C, Olivari N, Piccirelli S +5 more
Plain English This study looks at how to manage bleeding in the gastrointestinal tract caused by cancer. It shows that about 10% of cancer patients experience this type of bleeding, which is often hard to control. New imaging techniques and advanced treatment options, like special clips and hemostatic powders, are improving the ability to quickly stop the bleeding and make treatment more effective.
Who this helps: This benefits cancer patients and their doctors by providing better treatment options for gastrointestinal bleeding.
The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress.
2026
Diabetes, obesity & metabolism
Risi R, Pauletto D, Zanghi Buffi V, Berna V, Carafa A +11 more
Plain English This study looked at how having both type 1 diabetes and being overweight affects people's quality of life. Researchers found that individuals with both conditions experienced the worst outcomes, including higher levels of pain and more distress in social situations, compared to those with just one condition. Specifically, those with both conditions reported more pain and greater difficulty in physical activities.
Who this helps: Patients dealing with both type 1 diabetes and obesity can benefit from better treatment plans that address both conditions together.
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort Survey.
2026
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Nozza S, Masoero T, Tavelli A, Leserri F, Taramasso L +20 more
Plain English This study looked at how the availability of HIV prevention medication called PrEP changed in Italy after the government started reimbursing its costs in 2023. The number of people using PrEP jumped by 51.6% from 10,697 users in 2023 to 16,220 in 2024, with the biggest increases seen in regions like Sardinia and Friuli. While overall access improved, some areas still have a lot of unmet needs, particularly among specific groups.
Who this helps: This benefits individuals at risk of HIV, particularly in regions with high infection rates.
Fat Mass Influences Femur Bone Strength and Geometry Parameters, but Not Bone Mineral Density, in Autoimmune Diabetes: A Pilot Study.
2026
Diabetes/metabolism research and reviews
Risi R, Amendolara R, Abedi V, De Vita F, Barbaro F +8 more
Plain English This study looked at how extra body fat affects bone strength and shape in people with autoimmune diabetes, a condition that increases the risk of fractures. Researchers found that higher levels of body fat were linked to weaker bones in specific areas of the thigh bone (femur) and that being overweight had harmful effects, even when bone density appeared normal. These results show that just measuring bone density isn't enough to assess bone health; the amount of body fat is also important to consider for people with this condition.
Who this helps: This helps patients with autoimmune diabetes and their doctors in managing bone health.
Endoscopic submucosal dissection and submucosal tunneling endoscopic resection of gastric subepithelial lesions originating from the muscle layer: a multicenter retrospective study.
2026
Annals of gastroenterology
Dimitriadis S, Vogli S, Adrisani G, Tribonias G, Galasso D +26 more
Plain English This study looked at two advanced methods for removing gastric subepithelial lesions (SELs) that arise from the muscle layer of the stomach. Researchers found that these methods, endoscopic submucosal dissection (ESD) and submucosal tunneling endoscopic resection (STER), were effective in 96.3% of cases, with a low complication rate of 7% and very few recurrences (2.5% after about 9 months). This matters because these techniques can be safer alternatives to traditional surgery, especially for larger lesions or those growing outside the stomach lining.
Who this helps: Patients with gastric subepithelial lesions.
Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test-Based Organized Screening Program in Italy: A Randomized Control Trial.
2026
United European gastroenterology journal
Spada C, Cesaro P, Fuccio L, Salvi D, Ferrari C +17 more
Plain English This study looked at whether using computer assistance during colonoscopies could improve the detection of precancerous growths in people who had positive results from a fecal blood test for colorectal cancer. After analyzing over 1,000 patients, the researchers found that while there was no significant difference in finding advanced adenomas (21.3% with assistance vs. 20.5% without), the overall detection rate of adenomas was higher with computer assistance (67.6% vs. 59.8%). This is important because detecting more adenomas can help prevent cancer earlier.
Who this helps: This benefits patients undergoing colorectal cancer screening.
Corrigendum to Endoscopic powered resection device for residual colonic lesions: the first multicenter, prospective, international clinical study. Gastrointestinal Endoscopy Volume 99, Issue 5, May 2024, Pages 778-786.
2025
Gastrointestinal endoscopy
Knabe M, Maselli R, Cesbron-Metivier E, Hollerbach S, Petruzziello L +13 more
A comprehensive RCT in screening, surveillance, and diagnostic AI-assisted colonoscopies (ACCENDO-Colo study).
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Spada C, Salvi D, Ferrari C, Hassan C, Barbaro F +12 more
Plain English This study looked at how effective a new artificial intelligence tool is during colonoscopies compared to standard methods. The research included 1,158 patients and found that the AI tool detected more adenomas (precancerous growths) – 50.2% in the AI group versus 40.5% in the standard group. This is important because finding more adenomas early can potentially prevent cancer.
Who this helps: This benefits patients undergoing colonoscopy by improving the chances of early detection of precancerous conditions.
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes.
2025
Diabetes research and clinical practice
Amendolara R, Zampetti S, Siena A, D'Onofrio L, De Vita F +7 more
Plain English This study looked at how remaining insulin-producing cells in adults with type 1 diabetes (T1D) affect blood sugar control and risk of low blood sugar episodes. Researchers found that people with higher levels of a marker called C-peptide (median 52.9 pmol/L) experienced fewer low blood sugar incidents compared to those with lower C-peptide levels (median 21.0 pmol/L), and even a small amount of C-peptide (above 15.1 pmol/L) was linked to better blood sugar control. Understanding and maintaining some C-peptide production could help improve treatment outcomes for people with T1D and lessen their risk of hypoglycemia.
Who this helps: This helps patients with type 1 diabetes.
Clinical outcomes of endoscopic mucosal resection for large superficial nonampullary duodenal epithelial tumor: a single-center study.
2025
European journal of gastroenterology & hepatology
Barbaro F, Papparella LG, Chiappetta MF, Schepis T, Maresca R +6 more
Plain English This study looked at a treatment called endoscopic mucosal resection (EMR) for large tumors in the duodenum, a part of the small intestine. Researchers reviewed the outcomes of 81 patients who had tumors over 1 cm in size from 2017 to 2021 and found that while 94% had their tumors successfully removed, 20% experienced recurrence within an average follow-up of 20.5 months, particularly among those with larger tumors or prior surgeries. This matters because, even though EMR can effectively treat these tumors, there is a significant chance they may come back, highlighting the need for regular check-ups.
Who this helps: Patients with large duodenal tumors and their doctors.
Sexual health knowledge, interest and acceptability of preexposure prophylaxis in migrant women.
2025
AIDS (London, England)
Mazzitelli M, Krankowska D, Cozzolino C, Scaglione V, Barbaro F +4 more
Plain English This study looked at how much migrant women in Padua, Italy, know about sexual health and preexposure prophylaxis (PrEP), a medication that reduces the risk of HIV. Out of 221 women surveyed, only 28.5% were aware of PrEP, and just 16.7% were willing to use it after receiving information about it. These findings show a significant gap in sexual health knowledge and access, indicating the need for targeted programs to improve awareness and reduce HIV/STI risks in this vulnerable group.
Who this helps: This helps migrant women by improving their access to sexual health information and services.
Erratum to "A comprehensive RCT in screening, surveillance, and diagnostic AI-assisted colonoscopies (ACCENDO-Colo study)" [Digestive and Liver Disease 57 (2025) 762-9].
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Spada C, Salvi D, Ferrari C, Hassan C, Barbaro F +12 more
Endoscopic Submucosal Dissection as a Rescue Therapy for Ineffective Endoscopic Mucosal Resection in Ileal Pouch, Nongranular, Laterally Spreading Tumor.
2025
ACG case reports journal
Grande G, Casciola R, Barbaro F, Schepis T, Cocca S +3 more
Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity.
2025
AIDS and behavior
Menozzi M, Trapani MDD, Burastero GJ, Volpi S, Cuomo G +6 more
Plain English This study looked at the health data of 244 people in Italy who used a preventive medication for HIV called PrEP from 2019 to 2022. It found that the rates of certain sexually transmitted infections (STIs) like gonorrhea rose, especially after 2020, with incidents increasing to about 10.3% for gonorrhea in 2021. There were also some cases of kidney problems, but serious issues were rare, affecting only one person enough to stop treatment.
Who this helps: This information benefits patients using PrEP and healthcare providers by emphasizing the need for regular STI testing and treatment.
Prophylactic Rectal ESD (Endoscopic Submucosal Dissection) Defect Closure and Post-ESD Clinical Outcomes: An International Multi-Center Study (with Video).
2025
Digestive diseases and sciences
Kumar AR, Madaka P, Le J, Ines RD, Tolosa C +22 more
Plain English This study looked at whether closing the wounds left after a specific type of rectal surgery (called ESD) helps prevent complications and reduces hospital stays. Out of 385 patients, 43% had their surgery wounds closed, resulting in lower overnight hospital stays (17% for closed wounds compared to 37% for open wounds). Although closing the wounds didn’t completely eliminate complications, no delayed perforations occurred in the closed group, highlighting the potential benefit of this technique.
Who this helps: This research benefits patients undergoing rectal ESD and their doctors by providing insights on minimizing complications and hospital stays.
Bilayer target for efficient production ofSc from proton-induced irradiation.
2025
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Canton L, Barbaro F, Lashko Y, De Dominicis L, Mou L +1 more
Plain English This study looked at a new way to produce a medical substance called Scandium (Sc) for use in nuclear medicine. Researchers used a special two-layer target made of natural vanadium and enriched titanium, which increased the production efficiency of Sc while keeping it pure. This is important because having a high-quality Sc is essential for treating patients accurately with precision medicine.
Who this helps: Doctors and patients who rely on accurate treatments in nuclear medicine.
Endoscopic submucosal dissection for gastric neuroendocrine neoplasms: A multicenter retrospective study.
2025
Journal of neuroendocrinology
Lazaridis N, Rimondi A, Chacchi-Cahuin R, Lemmers A, Costa D +21 more
Plain English This study looked at the effectiveness of endoscopic submucosal dissection (ESD) for treating gastric neuroendocrine tumors (G-NETs) in Western medical centers. Researchers analyzed data from 73 procedures performed on 69 patients and found that 94.5% of cases had complete resection and that 79.5% were fully successful in removing the tumors without any signs of disease left behind. Only a few patients experienced complications, indicating that ESD is a safe and effective option for treating these tumors.
Who this helps: This benefits patients with gastric neuroendocrine tumors and their doctors by providing a strong treatment option.
Hospital-cyclotrons production of high-purityTb viaGd(p,n).
2025
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Barbaro F, Canton L, Uzunov N, De Nardo L, Meléndez-Alafort L
Plain English This study focused on producing high-quality terbium, which is important for medical imaging. The researchers found that using a specific method involving the reaction of gadolinium with protons, known as Gd(p,n), can help create pure terbium while reducing contamination, which is essential for better image quality. They emphasize that improving this production method can lead to safer and more effective imaging for patients.
Who this helps: This benefits patients who need accurate imaging for diagnosis and treatment.
How to deal with lower gastrointestinal defects: the role of endoscopy.
2025
Expert review of gastroenterology & hepatology
Matteo MV, Santi G, Bove V, De Siena M, Gualtieri L +4 more
Plain English This study looked at problems in the lower part of the digestive system, like leaks and perforations, and how endoscopy can be used to treat them. It found that endoscopic methods, like using clips and stents, offer less invasive options than traditional surgery, which is important since these defects often lead to severe health issues. However, there is still a need for more research to create standardized treatment guidelines.
Who this helps: This benefits patients dealing with lower gastrointestinal issues and healthcare providers looking for effective treatment options.
Multiparametric ultrasound for the prediction of the short-term outcome after esophageal varices band ligation.
2025
World journal of gastroenterology
Ainora ME, Borriello R, Pecere S, Paratore M, Galasso L +13 more
Plain English This study examined how well multiparametric ultrasound can predict whether esophageal varices, which are swollen veins in the esophagus, can be successfully treated with a procedure called endoscopic variceal band ligation (EVBL) in patients with liver cirrhosis. Out of 41 patients, 28 (68.3%) had successful treatment after one month, while 13 (31.7%) needed another procedure. The findings showed that changes in liver and spleen stiffness measurements, along with ultrasound imaging, could help predict treatment outcomes, reducing the need for follow-up endoscopy.
Who this helps: This helps patients with cirrhosis by providing a non-invasive way to predict treatment success.
Effect of Prophylactic Colon ESD (Endoscopic Submucosal Dissection) Defect Closure on Post-ESD Outcomes: An International Multi-center Retrospective Study.
2025
Digestive diseases and sciences
Karna R, Sánchez JC, Josloff K, Tran T, Tiankanon K +27 more
Plain English This study looked at whether closing the wounds made during a specific colon procedure called endoscopic submucosal dissection (ESD) can help reduce complications, such as bleeding and the need to stay overnight in the hospital. The researchers found that among 560 patients, those who had their wounds closed experienced much lower rates of delayed bleeding (1.7% compared to 5.6%) and less need for overnight hospitalization. Specifically, closing the wounds reduced the risk of delayed bleeding for patients with right-sided polyps by more than half.
Who this helps: This benefits patients undergoing colon ESD, especially those with right-sided polyps.
Advanced diagnostic and resection endoscopic techniques in managing colitis-associated neoplasia: standard of care or still utopia?
2025
Best practice & research. Clinical gastroenterology
Maresca R, Calabrese G, Marchitto SA, Schepis T, Pecere S +5 more
Plain English This research looked at how to effectively detect and treat abnormal growths in patients with long-standing inflammatory bowel disease (IBD), which can lead to cancer. They found that choosing the right endoscopic technique is crucial: smaller lesions can be removed with a simpler method, while larger or tougher ones require more advanced techniques to ensure complete removal. Improving these methods is important because it can lead to better health outcomes and potentially reduce the need for major surgeries in patients at risk for cancer due to IBD.
Who this helps: This benefits patients with inflammatory bowel disease and their doctors.
Rates of Cancer, Non-curative Resection, Adverse Event and Surgery After Colonic Endoscopic Submucosal Dissection (ESD)-Results from a Large International Multicenter Study.
2025
Digestive diseases and sciences
Karna R, Sánchez JC, Josloff K, Tran T, Tiankanon K +27 more
Plain English This study looked at the outcomes of a procedure called endoscopic submucosal dissection (ESD) used to remove lesions from the colon, specifically focusing on how often cancer was found and how many patients needed further surgery. They found that cancer was present in 12% of the cases, and more than half (59.1%) of the patients had what is called non-curative resection, meaning the procedure didn’t completely remove the cancer. Importantly, only 7.6% of those with non-curative resections needed additional surgery, and there were some complications in 8.8% of patients. This information is important as it shows the need for careful patient and lesion selection to improve outcomes for those undergoing ESD.
Who this helps: This helps doctors and patients considering ESD for colon lesions.
Stenosis development after circumferential colorectal endoscopic submucosal dissection: a multicenter analysis of predictive factors and outcomes.
2025
Gastrointestinal endoscopy
Sferrazza S, Calabrese G, Maida M, Andrisani G, Madkour A +33 more
Plain English This study looked at patients who had a special procedure called endoscopic submucosal dissection (ESD) to remove large colorectal tumors that affected more than 90% of the bowel's circumference. They found that 34.2% of patients developed a narrowing (stenosis) of the bowel after this procedure, with a higher rate in those with rectal lesions (38.2%) compared to colon lesions (11.6%). Despite the high risk of stenosis, all cases were successfully treated without needing surgery, making ESD a safe option for removing these tumors.
Who this helps: Patients undergoing colorectal ESD and their doctors.
Performance of endoscopic submucosal dissection and submucosal tunneling endoscopic resection for esophageal submucosal tumors: A multicenter retrospective cohort study.
2025
Annals of gastroenterology
Fousekis F, Mpakogiannis K, Vogli S, Barret M, Marin FS +20 more
Plain English This study looked at two methods for removing esophageal tumors called endoscopic submucosal dissection (ESD) and submucosal tunneling endoscopic resection (STER). Researchers found that these methods had a high success rate of 95% for removing tumors, with no significant difference between the two techniques (92% success for STER and 98% for ESD). This is important because it shows that these less invasive procedures can replace traditional surgery for treating esophageal tumors, leading to quicker recoveries and fewer complications.
Who this helps: This helps patients with esophageal tumors by offering safer and more effective treatment options.
Unveiling the effectiveness of Chat-GPT 4.0, an artificial intelligence conversational tool, for addressing common patient queries in gastrointestinal endoscopy.
2025
iGIE : innovation, investigation and insights
Calabrese G, Maselli R, Maida M, Barbaro F, Morais R +4 more
Plain English This study examined how well Chat-GPT 4.0, an AI tool, can answer common questions from patients about gastrointestinal (GI) endoscopy. It found that most of the answers were reliable (94.4%) and accurate (100%), with a fair level of understandability (61.1%). This is important because it shows that AI can effectively provide useful information to patients, although healthcare professionals are still needed for some complex topics.
Who this helps: Patients seeking information about GI procedures.
Neoplastic risk in hyperplastic esophagogastric junction lesions: Comprehensive multicenter study.
2025
Endoscopy international open
De Cristofaro E, Barbaro F, Rivory J, Lupu A, Neri B +28 more
Plain English This study examined rare growths at the junction of the esophagus and stomach, known as hyperplastic esophagogastric junction (EGJ) lesions, to see if some of them could develop into cancer. Out of 91 patients, 21 lesions (or 23%) were found to have changed to a more dangerous form, including cancer. The researchers identified specific signs that increased the risk of cancer, such as the lesion being larger than 12 mm, having surface ulcers, or lacking a polyp-like shape, which suggests that careful monitoring and management of these lesions is crucial.
Who this helps: This research benefits patients with hyperplastic EGJ lesions and the doctors treating them by improving diagnosis and management strategies.
Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease.
2025
Endoscopy
Maselli R, de Sire R, Barbaro F, Cecinato P, Andrisani G +21 more
Plain English This study looked at a treatment called endoscopic submucosal dissection (ESD) for patients with inflammatory bowel disease (IBD) who have high-risk growths that could turn into colorectal cancer. Out of 91 patients treated, 95.8% had complete removals of the tumors, and only 12.5% faced any complications, all of which were managed without surgery. These positive results show that ESD is a useful option for treating these dangerous growths in IBD patients.
Who this helps: Patients with inflammatory bowel disease at risk of colorectal cancer.
Impact of age and comorbidities on colorectal endoscopic submucosal dissection outcomes: Large multicenter study in a Western cohort.
2025
Endoscopy international open
Sferrazza S, Calabrese G, Maida M, Capogreco A, de Sire R +18 more
Plain English This study looked at the outcomes of a common treatment for colon lesions called endoscopic submucosal dissection (ESD) in older patients, specifically comparing those over 80 years old to those aged 65-79. The researchers analyzed data from 980 patients and found that while most procedure results were similar between the two age groups, older patients had a higher risk of experiencing delirium after the procedure (2.2% compared to 0.1%). Additionally, patients with other health problems faced more complications overall.
Who this helps: This information benefits doctors and patients by highlighting the importance of careful monitoring for older patients undergoing this procedure.
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges.
2025
Expert review of gastroenterology & hepatology
Severino A, Marchitto SA, Bisegna P, Porcari S, Rondinella D +9 more
Plain English Researchers studied the gut microbiome to see if it could be used as a new tool for screening colorectal cancer (CRC), which is a major health issue worldwide. They found that specific patterns of bacteria in the gut could accurately tell apart individuals with CRC from healthy individuals. This finding is important because it opens the door to creating noninvasive screening tests that could reduce the need for uncomfortable procedures like colonoscopies and catch cancer earlier.
Who this helps: This helps patients and doctors by providing a less invasive way to detect colorectal cancer.
Endoscopic powered resection device for residual colonic lesions: the first multicenter, prospective, international clinical study.
2024
Gastrointestinal endoscopy
Knabe M, Maselli R, Cesbron-Metivier E, Hollerbach S, Petruzziello L +13 more
Plain English This study looked at a new tool called the endoscopic powered resection (EPR) device, designed to remove difficult, scarred growths in the colon known as adenomas. Out of 45 patients treated, the device successfully removed the lesions in 98% of cases, but nearly half (46.7%) of the patients still had residual disease after the first treatment, indicating that more than one procedure may be needed. The findings are important because they show that while the EPR device is generally safe and effective, patients may require additional treatments rather than surgery.
Who this helps: This benefits patients with difficult-to-remove colorectal lesions and their doctors by providing a less invasive treatment option.
Endoscopic full-thickness resection vs. endoscopic submucosal dissection of residual/recurrent colonic lesions on scars: a retrospective Italian and Japanese comparative study.
2024
European journal of gastroenterology & hepatology
Barbaro F, Papparella LG, Chiappetta MF, Ciuffini C, Fukuchi T +8 more
Plain English This study compared two methods for removing leftover or recurring lesions in the colon: endoscopic full-thickness resection (eFTR) and endoscopic submucosal dissection (ESD). Researchers found that both methods had similar success rates in fully removing the lesions, with 90% for eFTR and 95% for ESD, and the procedures took the same amount of time. However, eFTR had no cases of perforation, while ESD had a 26% rate of perforation, making eFTR a safer option.
Who this helps: This benefits patients with recurring colon lesions who need safer treatment options.
Tb production by cyclotrons: what level ofGd enrichment allows clinical applications?
2024
EJNMMI physics
Barbaro F, Canton L, Uzunov N, De Nardo L, Melendez-Alafort L
Plain English This study looked at how to produce the radioactive material terbium (Tb) for use in medical imaging, specifically focusing on the role of gadolinium (Gd) in the production process. Researchers found that using Gd that is enriched to no more than 2% is key to minimizing unwanted radioactive byproducts while still allowing for high-quality imaging. With these conditions met, Tb can be safely produced for clinical use, ensuring that patients receive accurate scans without excessive radiation exposure.
Who this helps: Patients needing accurate diagnostic imaging.
Safety and efficacy of salvage endoscopic submucosal dissection for Barrett's neoplasia recurrence after radiofrequency ablation.
2024
Endoscopy
Mesureur L, Deprez PH, Bisschops R, Pouw RE, Weusten BLAM +18 more
Plain English This study looked at a procedure called salvage endoscopic submucosal dissection (ESD) to treat patients who had a return of Barrett's neoplasia after receiving radiofrequency ablation (RFA). Out of 56 patients, the treatment was mostly safe, with complications occurring in 11% of cases, and about 58.9% of patients experienced a complete removal of their cancerous tissue. Additionally, after an average follow-up time of 14 months, around 69.8% of patients were in remission from their neoplasia.
Who this helps: This benefits patients with Barrett's neoplasia who might face a recurrence after RFA.
Endoscopic submucosal dissection for rectal neuroendocrine tumours: A multicentric retrospective study.
2024
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Rimondi A, Despott EJ, Chacchi R, Lazaridis N, Costa D +17 more
Plain English This study looked at the effectiveness of a procedure called Endoscopic Submucosal Dissection (ESD) for treating rectal neuroendocrine tumors (R-NETs) in Western medical centers from 2015 to 2020. They found that out of 40 ESD procedures, 97.5% were completed successfully, and 87.5% achieved clean margins, meaning no cancer cells were left behind. Additionally, complications were low, with only one case of serious bleeding and one perforation, while the recurrence rate was just 2.5%.
Who this helps: This benefits patients with rectal neuroendocrine tumors who may need effective treatment options.
Management of fistulas in the upper gastrointestinal tract.
2024
Best practice & research. Clinical gastroenterology
Matteo MV, Birligea MM, Bove V, Pontecorvi V, De Siena M +4 more
Plain English This study looked at how to manage fistulas, which are abnormal connections in the upper part of the digestive system, often caused by illness or medical treatments. It found that various new endoscopic techniques—like special clips and stents—are available to treat these conditions with less invasive methods. This is important because it can lead to better recovery outcomes for patients who have these complex issues.
Who this helps: This helps patients dealing with upper gastrointestinal fistulas.
Correlation between tooth decay and insulin resistance in normal weight males prompts a role for myo-inositol as a regenerative factor in dentistry and oral surgery: a feasibility study.
2024
Frontiers in bioengineering and biotechnology
Barbaro F, Conza GD, Quartulli FP, Quarantini E, Quarantini M +9 more
Plain English This research studied the link between tooth decay and insulin resistance in normal weight young men. The findings showed that men with more tooth decay had higher signs of insulin resistance, with significant correlations between tooth decay and factors like body fat and muscle strength. This matters because it suggests that a compound called myo-inositol could help improve dental health by supporting cell repair processes affected by insulin resistance.
Who this helps: Patients with dental issues and insulin resistance.
Perinatal exposure to Aroclor 1254 disrupts thyrotropin-releasing hormone mRNA expression in the paraventricular nucleus of male and female rats.
2024
Toxicology
Sánchez-Jaramillo E, Sánchez-Islas E, Gómez-González GB, Yáñez-Recendis N, Mucio-Ramírez S +3 more
Plain English This study looked at how a chemical called Aroclor 1254, which is a type of industrial pollutant, affects a hormone that helps regulate thyroid function in rats. Researchers found that rats exposed to this chemical during pregnancy had lower levels of this hormone (called TRH) after being put under stress from dehydration, with TRH levels decreasing significantly in both male and female rats exposed to Aroclor 1254. This is important because it shows that exposure to certain pollutants can impair the body’s ability to respond to stress and may lead to thyroid problems later in life.
Who this helps: This helps patients and healthcare providers by highlighting the potential long-term health effects of environmental pollutants.
Endoscopic sleeve gastroplasty for metabolic dysfunction-associated steatotic liver disease.
2024
Expert review of gastroenterology & hepatology
Matteo MV, Gualtieri L, Bove V, Palumbo G, Pontecorvi V +4 more
Plain English This study looked at endoscopic sleeve gastroplasty (ESG), a weight loss procedure, as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD), which affects about one-third of people worldwide and is related to obesity. The research showed promising results where ESG helped improve liver health markers in patients, but most studies were small and did not involve random comparisons. This matters because effective treatments for MASLD are needed, especially when traditional weight loss methods fail.
Who this helps: Patients with obesity and liver disease.
Impenetrable Abdomen: A Case Report of Endoscopic Sleeve Gastroplasty Performed in Patient with Huge Paramedian Laparocele.
2024
Obesity surgery
De Siena M, Gualtieri L, Bove V, Pontecorvi V, Matteo MV +4 more
Plain English This study examined the use of endoscopic sleeve gastroplasty (ESG) in a 56-year-old woman who had extreme obesity and a condition called "impenetrable abdomen," which made traditional surgery difficult. After the ESG procedure, her body mass index (BMI) dropped from 47.1 to 34.9 in just six months, and she was able to stop using a machine for her sleep apnea. This matters because it shows that ESG can safely and effectively help patients who are not candidates for standard surgical options and leads to significant health improvements.
Who this helps: This benefits patients with severe obesity who face challenges undergoing traditional bariatric surgery.
Fugitive Acromegaly: A Historical, Clinical, and Translational Perspective.
2024
Frontiers of hormone research
Toni R, Barbaro F, Di Conza G, Elviri L, Mosca S +5 more
Plain English This research paper looks at a rare condition called "fugitive acromegaly," where patients show symptoms of a hormone imbalance related to growth but have complex and inconsistent hormone levels. The study found that patients often have aggressive pituitary tumors, with two key types identified—Acidophil Stem Cell Tumors (ASCTs) and Sparsely Granulated Somatotroph Tumors (SGSTs). These tumors respond poorly to standard treatments; specifically, ASCTs mainly produce prolactin, while SGSTs produce growth hormone, making treatment challenging.
Who this helps: This information helps doctors better understand and treat patients with complex cases of acromegaly.
Endoscopic Local Excision (ELE) with Knife-Assisted Resection (KAR) Techniques Followed by Adjuvant Radiotherapy and/or Chemotherapy for Invasive (T1bsm2,3/T2) Early Rectal Cancer: A Multicenter Retrospective Cohort.
2024
Journal of clinical medicine
Tribonias G, Papaefthymiou A, Zormpas P, Seewald S, Zachou M +12 more
Plain English This study looked at how well endoscopic local excision with knife-assisted techniques, followed by either radiation or chemotherapy, works for patients with early-stage rectal cancer who might not be able to have traditional surgery. Out of 51 patients treated, 98% had successful initial resections, but about 14% experienced a recurrence of cancer within an average of 9 months. This approach offers a safe and effective alternative for controlling cancer without needing surgery, which is important for patients who cannot undergo more invasive procedures.
Who this helps: This benefits patients with early rectal cancer who are not candidates for surgery.
How to preserve the native or reconstructed esophagus after perforations or postoperative leaks: A multidisciplinary 15-year experience.
2024
World journal of gastrointestinal surgery
Nachira D, Calabrese G, Senatore A, Pontecorvi V, Kuzmych K +19 more
Plain English This study looked at how to treat patients with tears or leaks in their esophagus—either from injuries or surgery—over a 15-year period, involving 60 patients. They found that 56 of these patients were successfully treated using minimally invasive methods without needing to remove the esophagus, with an average recovery time of about 55 days. Only one patient died, and serious complications were rare, showing that working together across different medical specialties can effectively manage these serious conditions and keep the esophagus intact.
Who this helps: Patients facing esophageal injuries or leaks and their doctors.
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV).
2024
Viruses
Quaranta MG, Cavalletto L, Russo FP, Calvaruso V, Ferrigno L +25 more
Plain English This study looked at the impact of treating hepatitis C with direct-acting antivirals (DAAs) on the risk of developing liver cancer (hepatocellular carcinoma, or HCC) in patients with severe liver disease (cirrhosis). It found that patients who were treated and cured of hepatitis C had a lower risk of developing HCC compared to those who remained untreated—specifically, the untreated group had a 64% higher risk of developing liver cancer. This is important because it shows that successfully treating hepatitis C not only eliminates the virus but significantly reduces the likelihood of a serious cancer developing.
Who this helps: Patients with hepatitis C and liver cirrhosis.
Plain English This study examined patients with chronic Hepatitis D virus (HDV) infection in Italy, focusing on their health profiles and whether they could qualify for certain treatments. Out of 5,492 patients tested, 422 (10.2%) were found to be positive for HDV, with many of these patients being younger and having existing liver conditions like cirrhosis or cancer. The findings highlight that a significant number of patients have other health issues that could limit their treatment options, particularly affecting 53% of them.
Who this helps: This helps patients with chronic Hepatitis D and their doctors by providing insights into treatment eligibility and the prevalence of other health problems.